Ghana

in page functions
[French]
Total population (2016) 28,033,366
Birth cohort (2016) 888,013
Surviving Infants (surviving to 1 year per year, 2016) 845,331
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 43/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 62/1000
World Bank Index, IDA (2012) 3.88
Co-financing status (2016) Preparatory transition
No. of districts/territories (2014) 216

Gavi support for Ghana

Type of support

Approvals

2001-2020 (US$)
(31 Mar 2016)

Commitments

2001-2020 (US$)
(31 Mar 2016)

Disbursements

2000-2016 (US$)
(31 Mar 2016)

% Disbursed

(31 Mar 2016)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Cash Support (CASHSUPP) $170,000 $195,000 $170,000 100%
Civil Society Organisation support (CSO) $765,000 $765,000 $832,909 109%
Health system strengthening (HSS 1) $9,670,000 $9,670,000 $9,670,000 100%
Health system strengthening (HSS 2) $7,739,496 $18,059,296 $4,299,400 56%
HPV Demo (NVS) $188,885 $188,885 $190,108 101%
Immunisation services support (ISS) $5,316,620 $5,316,620 $5,316,620 100%
Injection safety support (INS) $855,300 $855,300 $855,300 100%
IPV (NVS) $1,536,942 $2,594,942 $872,102 57%
Measles (NVS) $1,726,057 $1,726,057 $1,357,348 79%
Measles-Rubella (NVS) $7,750,269 $7,750,269 $7,750,269 100%
Meningitis A (NVS) $724,500 $1,647,000
Meningitis A - campaign (NVS) $2,037,743 $2,037,743 $2,037,743 100%
Meningitis A - mini catch-up campaign (NVS) $656,000 $656,000
Meningitis A - mini catch-up op.costs (OPC) $524,500 $524,500
Meningitis A - operational costs (OPC) $1,949,753 $1,949,753 $1,949,753 100%
MR - Operational costs (OPC) $7,522,000 $7,522,000 $7,522,000 100%
Penta (NVS) $92,612,255 $92,612,255 $94,360,652 102%
Pneumo (NVS) $68,650,205 $77,154,205 $72,609,207 106%
Rotavirus (NVS) $20,157,577 $23,195,077 $18,997,510 94%
Vaccine Introduction Grant (VIG) $2,534,000 $2,534,000 $2,534,000 100%
Yellow Fever (NVS) $9,782,007 $9,782,007 $9,867,991 101%
Total $242,869,109 $266,735,909 $241,192,912

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Ghana DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2014)

Grade of confidence


N/A
DTP3 - Official country estimates (2014) 98%
M:F sex ratio at birth (2016) 1.05
Household survey: DTP3 coverage for male (2010) 92.70%
Household survey: DTP3 coverage for female (2010) 93.00%
Household survey: Last DTP3 survey (2010) 93%
% districts achieving > 80% DTP3 coverage (2014) 76%
% districts achieving < 50% DTP3 coverage (2014) 0%
MCV WHO/UNICEF estimates (2014) 92%

Breakdown of support

Non-vaccine support Vaccine support
14% 86%
$32,539,982 $208,042,926

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Ghana

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

10 November 2015

Gavi item

Scientists mark 'stunning success' of vaccine in virtually ridding Africa of meningitis A

New research forecasts a resurgence of meningitis A epidemics in 15 years should immunization efforts stall.

05 August 2014

Niger’s Minister of Health administers one of the first doses of vaccine to an infant.

Niger tackles its two biggest child killers with Gavi support

Life-saving pneumococcal and rotavirus vaccines are to be provided to all Niger’s children.

close icon

modal window here